A new biological enhancement therapy for anterior cruciate ligament reconstruction: the preclinical proof of anterior cruciate ligament reconstruction with tendon graft reseeded with autologous anterior cruciate ligament-derived cells
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index; 18 of the 68 sources its claims cite were checked for support.
Abstract
BACKGROUND: The current standard of care to treat a ruptured anterior cruciate ligament (ACL) is ACL reconstruction (ACLR), which involves replacing the torn ligament with a tendon graft. The implanted tendon graft undergoes a graft-maturation process known as ligamentization. However, the synthesis of type III collagen, which is typically found in weaker scar tissue, continues at higher concentrations, and the heterogeneous composition of collagen fibers of varying diameters of native ACL is never restored. Culture-expanded ACL-derived cells reseeded to tendon graft have shown the potential for enhanced ligamentization. We performed in vitro and in vivo studies of the outcomes of ACLR with decellularized tendon grafts reseeded with ACL-derived cells combined with acellularized cruciate ligament matrix (ACLM) powder as a biological scaffold. We hypothesized that this tissue-engineered construct would enhance the graft maturation process and mechanical properties of the graft following ACLR. METHODS: ACL-derived cells were harvested and isolated from remnants of ruptured ACLs within 4 weeks of injury in patients who had undergone ACLR. An ACLM was prepared from human ACL and posterior cruciate ligament tissues. Forty-five Sprague Dawley rats were randomly divided into 3 groups: a standard allograft group, an ACLM powder-only injection group, and an ACL-derived cells and ACLM powder co-injection group (e.g., target group). ACL-derived cells were mixed with ACLM powder and then injected into the decellularized tendon graft before ACLR. RESULTS: In vitro experiments found that combining ACLM powder and ACL-derived cells improved survival and integration of reseeded cells in the tendon extracellular matrix, resulting in the successful transplantation of ACL-derived cells. Animal ACLR experiments confirmed histologically improved structural maturation in cellularity, metaplasia, and restoration of collagen crimping in the graft reseeded with ACL-derived cells and ACLM powder. Enhanced gene expression of type I collagen resulted in superior mechanical properties of the tendon graft compared with the control groups. CONCLUSION: Implantation of a tendon graft reseeded with culture-expanded ACL-derived cells, and ACLM powder enhanced the tendon graft's maturation process and mechanical properties. We provide in vitro and in vivo proof-of-concept evidence supporting the efficacy of reseeding a tendon graft with ACL-derived cells combined with ACLM powder as a biological scaffold for ACL reconstruction.
Overview
CoChat Summary
TL;DR
This preclinical study tested whether reseeding decellularized tendon grafts with autologous ACL-derived cells plus acellularized cruciate ligament matrix (ACLM) powder could improve ACL reconstruction healing. In vitro and rat in vivo results showed better cell survival/integration, higher type I collagen expression, improved graft maturation, and stronger mechanical properties than controls.
Key findings
- In vitro, adding ACLM powder improved seeding efficiency; the 30 mg/mL ACLM group had significantly higher cell seeding efficiency than the 10 and 60 mg/mL groups (p < 0.001).
- In vitro, the target group showed more surviving/integrated cells on day 14 than ACL-derived cells alone (p < 0.001), stronger type I collagen staining, and higher type I collagen mRNA (p < 0.01); type III collagen, tenascin C, and smooth muscle A were not significantly different.
- In rat ACL reconstruction, the target group had less metaplasia at 4 weeks and more mature-looking cells and better collagen crimp restoration at 8 weeks than controls.
- Mechanical outcomes improved: ultimate failure load was 20.400 ± 0.949 N in the target group vs 13.125 ± 0.431 N in standard allografts, a 55.4% increase (p < 0.001); stiffness was 9.508 ± 1.020 N/mm vs 3.410 ± 0.942 N, a 178.8% increase (p = 0.005).
- Micro-CT showed increased new bone formation at the femoral tunnel (95.3% increase, p = 0.0219) and tibial tunnel (48.4% increase, p = 0.0113), with a higher tibial tunnel BV/TV ratio (27.6% increase, p = 0.0152).
Methods
- The study combined in vitro tendon-graft reseeding experiments and an in vivo rat ACL reconstruction model. Human ACL-derived cells came from 15 patients; ACLM powder came from 2 osteoarthritic donors.
- For rats, 45 male Sprague Dawley rats were randomized into 3 groups: standard allograft, ACLM powder-only injection, and ACL-derived cells + ACLM powder co-injection (target).
- Analyses included histology, immunohistochemistry/immunofluorescence, RT-qPCR, biosensor-based FRET imaging for talin tension and FAK activity, mechanical testing at 8 weeks, and micro-CT at 8 weeks.
Limitations
- The paper states that homogeneous injection of cells into the whole tendon graft was not possible, so results may not represent the entire graft.
- The ACL donors were mainly young males, so findings may not generalize to all patient populations.
- Only early time points (within 8 weeks) were analyzed, so long-term effects are unknown.
- The sample size at each time point was small and the study period was relatively short for mechanical assessment.
- The authors note that Sprague Dawley rat biomechanics differ from humans and that response to human-originated cells may vary between species; therefore, the findings cannot be generalized to humans.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
14 Valid · 1 Not valid · 15 Not checked · 76 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Although the implanted graft reportedly undergoes remodeling after 1 year, restoration of the mechanical strength of an intact ACL is not achieved even after 2 years [3, 4].”
§ A new biological enhancement therapy for anterior cruciate ligament reconstruction: the preclinical proof of anterior cruciate ligament reconstruction with tendon graft reseeded with autologous anterior cruciate ligament-derived cells > Background
What the sources say
- Partly supportedcites [3] Janssen RP, Scheffler SU. Intra-articular remodelling of hamstring tendon grafts after anterior cruciate ligament reconstruction. Knee Surg Sports Traumatol Arthrosc. 2014;22(9):2102–8. 23982759 PMC4142140 sourceExperimental — accuracy not yet measured
The Proliferation phase section says full mechanical strength was not restored even after two years in any in vivo model, in the context of animal studies. The Human hamstring remodelling and rehabilitation section says no final conclusion can be drawn about graft strength in humans because it cannot be measured in vivo. The claim omits that limitation and presents the two-year finding as applying generally after ACL reconstruction. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [4] Scheffler SU, Unterhauser FN, Weiler A. Graft remodeling and ligamentization after cruciate ligament reconstruction. Knee Surg Sports Traumatol Arthrosc. 2008;16(9):834–42. 18516592 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, the mechanical properties of the implanted graft, regardless of graft type, do not return to normal after ACLR surgery [3–5].”
§ A new biological enhancement therapy for anterior cruciate ligament reconstruction: the preclinical proof of anterior cruciate ligament reconstruction with tendon graft reseeded with autologous anterior cruciate ligament-derived cells > Background
What the sources say
- Partly supportedcites [3] Janssen RP, Scheffler SU. Intra-articular remodelling of hamstring tendon grafts after anterior cruciate ligament reconstruction. Knee Surg Sports Traumatol Arthrosc. 2014;22(9):2102–8. 23982759 PMC4142140 sourceExperimental — accuracy not yet measured
The Conclusion says hamstring tendon grafts adapt toward the intact ACL without fully restoring its mechanical properties. But the paper focuses on hamstring grafts, and the Human hamstring remodelling and rehabilitation section says no final conclusion can be drawn about mechanical strength in humans. It therefore does not establish the claim for every graft type after ACL reconstruction. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [4] Scheffler SU, Unterhauser FN, Weiler A. Graft remodeling and ligamentization after cruciate ligament reconstruction. Knee Surg Sports Traumatol Arthrosc. 2008;16(9):834–42. 18516592 source
- Partly supportedcites [5] Janssen RP, van der Wijk J, Fiedler A, Schmidt T, Sala HA, Scheffler SU. Remodelling of human hamstring autografts after anterior cruciate ligament reconstruction. Knee Surg Sports Traumatol Arthrosc. 2011;19(8):1299–306. 21293848 PMC3136699 sourceExperimental — accuracy not yet measured
The Discussion reports that animal grafts did not fully regain the mechanical strength of an intact ACL, reaching only 50–60% of its failure strength. But this does not establish that mechanical properties never return to normal in humans or regardless of graft type; the paper’s own conclusion concerns incomplete remodelling of human hamstring grafts up to two years after reconstruction. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, the predominant synthesis of type III collagen, which is typically found in weaker scar tissue, continues at higher concentrations, and the heterogeneous composition of collagen fibers of varying diameters of native ACL is never restored [5, 11, 12].”
§ A new biological enhancement therapy for anterior cruciate ligament reconstruction: the preclinical proof of anterior cruciate ligament reconstruction with tendon graft reseeded with autologous anterior cruciate ligament-derived cells > Background
What the sources say
- Partly supportedcites [5] Janssen RP, van der Wijk J, Fiedler A, Schmidt T, Sala HA, Scheffler SU. Remodelling of human hamstring autografts after anterior cruciate ligament reconstruction. Knee Surg Sports Traumatol Arthrosc. 2011;19(8):1299–306. 21293848 PMC3136699 sourceExperimental — accuracy not yet measured
The Discussion reports that a cited study of patellar-tendon grafts did not find the native ACL’s mean collagen-fibril diameter or bimodality restored during a transformation period of up to two years. This paper’s own Results concern collagen orientation, not fibril diameters, and neither finding establishes that the native diameter distribution is never restored after reconstruction. Page numbers are unavailable in our copy. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [11] Unterhauser FN, Bail HJ, Hoher J, Haas NP, Weiler A. Endoligamentous revascularization of an anterior cruciate ligament graft. Clin Orthop Relat Res. 2003(414):276–88. 12966303 source
- Not checked — no full text of the sourcecites [12] Weiler A, Forster C, Hunt P, Falk R, Jung T, Unterhauser FN, et al. The influence of locally applied platelet-derived growth factor-BB on free tendon graft remodeling after anterior cruciate ligament reconstruction. Am J Sports Med. 2004;32(4):881–91. 15150033 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In a recent in vitro study, we demonstrated that reseeding culture-expanded ACL-derived cells to a decellularized tendon graft enhanced the graft’s ability to survive and integrate into the tendon’s extracellular matrix (ECM), resulting in a higher gene expression level of type I collagen compared with mesenchymal stem cells derived from adipose tissue, which may lead to the normal ligamentization”
§ A new biological enhancement therapy for anterior cruciate ligament reconstruction: the preclinical proof of anterior cruciate ligament reconstruction with tendon graft reseeded with autologous anterior cruciate ligament-derived cells > Background
What the sources say
- Supportedcites [22] Park J, Jo S, Lee MK, Kim TH, Sung IH, Lee JK. Comparison of ligamentization potential between anterior cruciate ligament-derived cells and adipose-derived mesenchymal stem cells reseeded to acellularized tendon allograft. Bone Joint Res. 2022;11(11):777–86. 36342052 PMC9680201 source
The Discussion reports that ACL-derived cells reseeded onto acellularized tendon grafts survived and integrated into the tendon ECM better than adipose-derived mesenchymal stem cells, with higher type I collagen gene expression at seven days. It describes a possible contribution to ligamentization, not a demonstrated in vivo outcome. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In a recent in vitro study, we demonstrated that reseeding culture-expanded ACL-derived cells to a decellularized tendon graft enhanced the graft’s ability to survive and integrate into the tendon’s extracellular matrix (ECM), resulting in a higher gene expression level of type I collagen compared with mesenchymal stem cells derived from adipose tissue, which may lead to the normal ligamentization”
§ A new biological enhancement therapy for anterior cruciate ligament reconstruction: the preclinical proof of anterior cruciate ligament reconstruction with tendon graft reseeded with autologous anterior cruciate ligament-derived cells > Background
What the sources say
- Supportedcites [22] Park J, Jo S, Lee MK, Kim TH, Sung IH, Lee JK. Comparison of ligamentization potential between anterior cruciate ligament-derived cells and adipose-derived mesenchymal stem cells reseeded to acellularized tendon allograft. Bone Joint Res. 2022;11(11):777–86. 36342052 PMC9680201 source
The Key messages report significantly higher type I collagen gene expression in grafts reseeded with ACL-derived cells than in grafts reseeded with adipose-derived mesenchymal stem cells. The Discussion specifies that this was observed in acellularized tendon grafts at seven days and also reports better cell survival and integration into the matrix. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
65 more claims · 5 with their cited sources checked
Create a free account to see all 106 claims and to verify the 5 references still open.
- Probably not a substantial claim. 17
- It may state two separate claims as one. 21
- The quote only partly states this claim. 1
Citations
Cites
Claes, S., Verdonk, P., Forsyth, R., & Bellemans, J. (2011) · The American Journal of Sports Medicine · doi:10.1177/0363546511402662 · Cited by 412
Histological Changes in the Human Anterior Cruciate Ligament After Rupture*
MURRAY, M. M., MARTIN, S. D., MARTIN, T. L., & SPECTOR, M. (2000) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200010000-00004 · Cited by 398
Talin – the master of integrin adhesions
Klapholz, B., & Brown, N. H. (2017) · Journal of Cell Science · doi:10.1242/jcs.190991 · Cited by 309
Graft remodeling and ligamentization after cruciate ligament reconstruction
Scheffler, S. U., Unterhauser, F. N., & Weiler, A. (2008) · Knee Surgery, Sports Traumatology, Arthroscopy · doi:10.1007/s00167-008-0560-8 · Cited by 266
Sánchez, M., Anitua, E., Azofra, J., Prado, R., Muruzabal, F., & Andia, I. (2010) · Arthroscopy · doi:10.1016/j.arthro.2009.08.019 · Cited by 235
Ballock, R. T., Woo, S. L., Lyon, R. M., Hollis, J. M., & Akeson, W. H. (1989) · Journal of Orthopaedic Research · doi:10.1002/jor.1100070404 · Cited by 230
“Biological failure” of the anterior cruciate ligament graft
Ménétrey, J., Duthon, V. B., Laumonier, T., & Fritschy, D. (2008) · Knee Surgery, Sports Traumatology, Arthroscopy · doi:10.1007/s00167-007-0474-x · Cited by 227
Janssen, R. P. A., & Scheffler, S. U. (2014) · Knee Surgery, Sports Traumatology, Arthroscopy · doi:10.1007/s00167-013-2634-5 · Cited by 225
Revascularization and ligamentization of autogenous anterior cruciate ligament grafts in humans
Falconiero, R., DiStefano, V., & Cook, T. (1998) · Arthroscopy · doi:10.1016/s0749-8063(98)70041-6 · Cited by 219
Development of fibroblast‐seeded ligament analogs for ACL reconstruction
Dunn, M. G., Liesch, J. B., Tiku, M. L., & Zawadsky, J. P. (1995) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820291107 · Cited by 206
Research works printed but not linked: 1
- Scheffler S, Dustmann M, Gangey I, Schulz T, Unterhauser F, Weiler A. The biological healing and restoration of the mechanical properties of free soft-tissue allografts lag behind autologous ACL reconstruction in the sheep model. Trans Orthop Res. 2005;51:0236.
Cited by
Simon, F., Caneparo, C., Moreira-Pereira, J., & Chabaud, S. (2026) · Bioengineering · doi:10.3390/bioengineering13040442 · Cited by 3
“ACL-derived stem or progenitor cells have shown promising results, notably in enhancing graft–bone integration after reconstruction [157,158] and exhibiting location-dependent differentiation potentials [159].”
Smaida, R., Maugard, L., Gegout, H., Arruebo, M., Fioretti, F., Benkirane-Jessel, N., & Favreau, H. (2026) · Polymers · doi:10.3390/polym18101239
Metadata
- Authors
- Park, J., Soh, H., Jang, Y.-K., Lee, Y. S., Lee, M.-K., Kim, H., Kim, T.-H., Alkhelaifi, K., Kim, T.-J., & Lee, J. K.
- Affiliations
- Hanyang University (KR)
- Pusan National University (KR)
- Hanyang University Hospital for Rheumatic Disease (KR)
- Qatar Orthopaedic and Sports Medicine Hospital (QA)
- Hanyang University Seoul Hospital (KR)
- Corresponding author
- Lee, Myung-Kyu
- Kim, Tae-Hwan
- Kim, Tae-Jin
- Lee, Jin Kyu
- ORCID
- Venue
- Stem Cell Research & Therapy
- Published
- 2025-11-14
- Volume
- 16
- Issue
- 1
- Pages
- 638-638
- ISSN
- 1757-6512 (ISSN-L)
- PMC
- PMC12619155
- OpenAlex
- W4416224747
- Cited by
- 3
- References
- 67
- Citations by year
- 2026: 3
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Stem Cell Research & Therapy (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation of Korea (2021R1A6A1A03038899)
- Korean Fund for Regenerative Medicine (RS-2023-00215515)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Tendon Structure and Treatment
- Health Sciences › Medicine › Surgery › Knee injuries and reconstruction techniques
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- anterior cruciate ligament reconstruction, biological scaffolds, graft maturation, ligamentization, type I collagen, graft mechanical properties, tissue engineering, rat model
- MeSH terms
- Anterior Cruciate Ligament Injuries, Animals, Female, Humans, Male, Tendons, Transplantation, Autologous, Anterior Cruciate Ligament, Rats, Sprague-Dawley, Tissue Engineering, Rats, Tissue Scaffolds, Anterior Cruciate Ligament Reconstruction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A new biological enhancement therapy for anterior cruciate ligament reconstruction: the preclinical proof of anterior cruciate ligament reconstruction with tendon graft reseeded with autologous anterior cruciate ligament-derived cells. https://app.cochat.ai/papers/10.1186/s13287-025-04760-1
- The paper
- Park, J., Soh, H., Jang, Y.-K., Lee, Y. S., Lee, M.-K., Kim, H., Kim, T.-H., Alkhelaifi, K., Kim, T.-J., & Lee, J. K. (2025). A new biological enhancement therapy for anterior cruciate ligament reconstruction: the preclinical proof of anterior cruciate ligament reconstruction with tendon graft reseeded with autologous anterior cruciate ligament-derived cells. Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-025-04760-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.